Home » Biotechnology » Page 2

Tag

Biotechnology

Articles and news on UK and European growth companies operating in the biotechnology sector who are leveraging scientific advancements to innovate in sectors such as healthcare, agriculture, industrial processes, and environmental sustainability.

News

Spin-out biomedical business gets SPARK Impact-led investment

The North West Fund for Biomedical and Fusion IP are coming together to back the growth ambition of University of Sheffield spin-out Absynth Biologics.

News

Imperial Innovations pulls in £30 million from EIB to invest in biotech

AIM-listed investment firm Imperial Innovations Group has secured a £30 million loan so that it can make investments in the biotech and therapeutics sectors.

News

NVM Private Equity supports European growth efforts of Cleveland Biotech

The management team of Cleveland Biotech has led a buy-out of the business with the help of new investor NVM Private Equity.

News

The North West Fund for Biomedical moves past £10 million mark with LumbaCurve backing

A £125,000 equity investment allocation has been secured by LumbaCurve International to aid in its efforts to conduct market development and a clinical effectiveness study for its lower back pain treatment.

News

Irish biotech firm Algae Health nets funding to target exporting

An investment of €1 million (£854,000) is set to allow biotech business Algae Health to recruit an extra 23 people in the coming three years.

News

New AIM placing for EpiStem to aid with development of Genedrive diagnostic

EpiStem, a biotechnology and personalised medicine company, has used its Alternative Investment Market listing to raise £4.3 million.

News

Kent biotech firm Ziarco secures Pfizer as backer and collects £3.75 million

UK-based biotech start-up Ziarco has closed the first tranche of what it reveals will be a £16.8 million Series A funding round.

News

Calcivis attracts host of angel backers from Archangels to continue dental development

A newly-formed Scottish biotech company has secured the backing it needs to develop its tooth decay assessment technology.

News

Cell Medica in tie-up with Imperial and Invesco

Imperial Innovations has closed its second July deal taking its total 2012 transactions, alongside other investors, to £62.6 million.

News

Spin-out business Glythera secures IP Group support

University of Bath spin-out Glythera has secured £2 million of development capital from IP Group.

News

Biotech business nets Foresight capital

A growth capital investment from Foresight Group means that Biofortuna will be able to target regulatory approvals in the US.

News

ADC Biotechnology secures funding for new antibody initiative

ADC Biotechnology has secured a package of investment and grants totalling £450,000 to expand development and commercialisation of its new antibody drug production technology.

Recommended Content